Results 101 to 110 of about 10,924,554 (370)

Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors – a biomarker analysis of the ALICE and ICON trials

open access: yesMolecular Oncology, EarlyView.
In this explorative biomarker analysis, we assessed serial sampling of circulating tumor cells (CTCs) with CellSearch in two randomized trials testing immune checkpoint inhibitors (ICIs) in metastatic breast cancer. Our data demonstrate a prognostic potential of CTCs, most apparent 4 weeks into ICI therapy.
Nikolai Kragøe Andresen   +13 more
wiley   +1 more source

Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis

open access: yesRespiratory Research, 2020
Background Serum chitotriosidase is a promising biomarker that has shown high specificity and sensitivity in patients with sarcoidosis. The aim of this study was to investigate correlations between serum chitotriosidase, clinical phenotypes, disease ...
David Bennett   +14 more
doaj   +1 more source

Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases

open access: yesEuropean Respiratory Journal, 2019
A proportion of patients with fibrosing interstitial lung diseases (ILDs) develop a progressive phenotype characterised by decline in lung function, worsening quality of life and early mortality.
L. Wollin   +7 more
semanticscholar   +1 more source

Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients

open access: yesMolecular Oncology, EarlyView.
Small cell lung cancer (SCLC) is an aggressive form of lung cancer that spreads rapidly to secondary sites such as the brain and liver. Cancer cells circulating in the blood, “circulating tumor cells” (CTCs), have demonstrated prognostic value in SCLC, and evaluating biomarkers on CTCs could guide treatment decisions such as for PARP inhibitors ...
Prajwol Shrestha   +6 more
wiley   +1 more source

Correction to: Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis

open access: yesRespiratory Research, 2020
After publication of our article [1] the authors have notified us that one of the names has been incorrectly tagged.
David Bennett   +14 more
doaj   +1 more source

Sarcoidosis of the pleura: A case report [PDF]

open access: yesVojnosanitetski Pregled, 2014
Introduction. Pleural involvement is an uncommon manifestation of sarcoidosis. It may manifest as pleural effusion, pneumothorax, pleural thickening and nodules, hydropneumothorax, trapped lung, hemothorax, or chylothorax.
Jovanović Dragana   +6 more
doaj   +1 more source

Prediction of repurposed drugs for treating lung injury in COVID-19 [PDF]

open access: yesarXiv, 2020
Coronavirus disease (COVID-19) is an infectious disease discovered in 2019 and currently in outbreak across the world. Lung injury with severe respiratory failure is the leading cause of death in COVID-19, brought by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
arxiv  

Convolutional neural networks based efficient approach for classification of lung diseases

open access: yesHealth Information Science and Systems, 2019
Treatment of lung diseases, which are the third most common cause of death in the world, is of great importance in the medical field. Many studies using lung sounds recorded with stethoscope have been conducted in the literature in order to diagnose the ...
Fatih Demir, A. Şengur, V. Bajaj
semanticscholar   +1 more source

Lung disease in the tropics [PDF]

open access: yesRevista do Instituto de Medicina Tropical de São Paulo, 1991
"Lung Immunology in the Tropics, Alimuddin Zumla and D. Geraint James Granulomatous Lung Diseases in the Tropics, Om P. Sharma and Gurdip S. Flora Pulmonary Complications of Malaria, Pradeep Bambery, Surinder K. Jindal, and Upjeet Kaur Melioidosis, Sumalee Kiatboonsri Pulmonary Complications of Brucellosis, A. R. Lulu and G. F.
openaire   +4 more sources

Home - About - Disclaimer - Privacy